TürkiyeSGK and reimbursement
SGK adds a drug for a rare disease affecting the optic nerve to reimbursement
A drug used for a rare disease affecting the optic nerve has been added to reimbursement coverage.
Official statement or regulation
Rare Diseases
News
New treatments, research and health policy from around the world and from Türkiye. Each with its source and level of evidence.
6 updates
TürkiyeSGK and reimbursement
Reimbursement criteria for nusinersen and risdiplam in SMA revised
The criteria for the use and reimbursement of nusinersen and risdiplam in SMA treatment have been revised.
Official statement or regulationSMA
TürkiyeSGK and reimbursement
SGK to add a drug used in cystic fibrosis treatment to reimbursement
SGK (Social Security Institution) announced that it will add a drug used to treat cystic fibrosis to the reimbursement list.
Official statement or regulationCystic fibrosis
TürkiyeSGK and reimbursement
A third SMA drug to be added to the reimbursement list, minister announces
Another drug used to treat children with SMA will be added to the SGK (Social Security Institution) reimbursement list.
Official statement or regulationSMA
TürkiyeSGK and reimbursement
16 drugs added to SGK reimbursement list, including one for a genetic nerve disease
With an amendment to the Sağlık Uygulama Tebliği (SUT, Health Implementation Communiqué), 16 drugs were added to the SGK (Social Security Institution) reimbursement list.
Official statement or regulation
TürkiyeHealth policy
2025 Annual Program: more rare disease centers, neuromuscular units to reach 30
The Ministry of Health will increase the number of treatment and research centers for rare diseases.
Official statement or regulation